A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo
Clinical trial NCT06015308 · COMPLETED
Trial details
- NCT number
- NCT06015308
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-06
- Primary completion
- 2025-10-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.